Close

Ocugen (OCGN) Enters Agreement With Washington University in St. Louis for Commercialization of Intranasal COVID-19 Vaccine in US, Europe and Japan

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 2/4/2023

1. AMZN
2. AAPL
3. GOOGL
4. MCHP
5. SPY
6. BILL
7. F
8. QCOM
9. GOOG
10. SBUX


Go back to Ocugen (OCGN) Enters Agreement With Washington University in St. Louis for Commercialization of Intranasal COVID-19 Vaccine in US, Europe and Japan
(NASDAQ: OCGN) Delayed: 1.29 -0.04 (3.01%)
Previous Close $1.33    52 Week High $ 
Open $1.29    52 Week Low $ 
Day High $1.35    P/E N/A 
Day Low $1.27    EPS $ 
Volume 4,961,731